Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe-Reference-Cited by-同舟云学术

Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe

Published:2015-05 Issue:5 Volume:67 Page:904-912
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fizazi Karim,Abrahamsson Per-Anders,Ahlgren Goran,Bellmunt Joaquim,Castellano Daniel,Culine Stephane,de Wit Ronald,Gillessen Silke,Gschwend Juergen E.,Hamdy Freddie,James Nicholas,McDermott Raymond,Miller Kurt,Wiegel Thomas,Wirth Manfred,Tombal Bertrand

Publisher

Elsevier BV

Subject

Urology

Reference45 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. International variation in prostate cancer incidence and mortality rates;Center;Eur Urol,2012

3. Prostate cancer: ESMO Consensus Conference guidelines 2012;Horwich;Ann Oncol,2013

4. Prostate-cancer mortality at 11 years of follow-up;Schröder;N Engl J Med,2012

5. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study;Bolla;Lancet Oncol,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Industry-Sponsored Trials (IST) and Investigator-Initiated Trials (IIT) in Advanced Genitourinary Cancers in the United States, Canada, United Kingdom and France;Clinical Genitourinary Cancer;2024-08

2. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design;The Lancet;2022-04

3. Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer;Japanese Journal of Clinical Oncology;2022-03-24

4. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry;Urologic Oncology: Seminars and Original Investigations;2020-10

5. Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer;BJUI Compass;2020-08-30